Physicians must remember they took an oath to “do no harm” and must act in accordance with it, even if their choices do not meet a patient’s preferences.
For myelodysplastic syndromes (MDS), bone marrow fibrosis (BMF) is an independent prognostic factor for MDS, according to a study published in Leukemia & Lymphoma. Furthermore, adding BMF into the Revised International...
In both the first-line and relapsed/ refractory setting, patients with chronic lymphocytic leukemia (CLL) treated with targeted therapies have longer median overall survival (OS), according to a study published in Clinical...